Publications by authors named "Craig Okada"

Claim this Profile
V
Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma.
Riyad N H Seervai, Craig Y Okada, Stephanie J Mengden-Koon, Noah I Hornick

JAAD Case Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study.
Kim M Linton, Umberto Vitolo, Wojciech Jurczak, Pieternella J Lugtenburg, Emmanuel Gyan, Craig Okada

Lancet Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study.
Swaminathan P Iyer, Auris Huen, Weiyun Z Ai, Deepa Jagadeesh, Mary J Lechowicz, Craig Okada

Haematologica· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes After Hematopoietic Cell Transplant in Peripheral T-Cell Lymphoma - The Oregon Health and Science University Experience.
Derek Galligan, Staci Williamson, Jessie Myers, Andy I Chen, Brandon Hayes-Lattin, Craig Okada

Clin Lymphoma Myeloma Leuk· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.
Olivia M Lucero, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu, Craig Okada

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.
Ahmad S Halwani, Carlos Panizo, Iris Isufi, Alex F Herrera, Craig Y Okada

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies.
Adam S Kittai, Scott Best, Bria Thurlow, Vi Lam, Taylor Hashiguchi, Craig Okada

Haematologica· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel somatic PLCG2 variant associated with resistance to BTK and SYK inhibition in chronic lymphocytic leukemia.
Vikram Raghunathan, Guang Fan, Adam S Kittai, Craig Okada, Alexey V Danilov

Eur J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.
Taylor Hashiguchi, Nur Bruss, Scott Best, Vi Lam, Olga Danilova, Craig Y Okada

Mol Cancer Ther· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.
Abby Wills, Guang Fan, Edward Kim, Craig Y Okada, Kevin P White

Dermatol Online J· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD47 in Sézary syndrome with SIRPαFc.
Lisa D S Johnson, Swati Banerjee, Oleg Kruglov, Natasja Nielsen Viller, Steven M Horwitz, Craig Okada

Blood Adv· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.
Scott Best, Taylor Hashiguchi, Adam Kittai, Nur Bruss, Cody Paiva, Craig Okada

Blood Adv· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.
Nathan D Gay, Eliana Kozin, Craig Okada, Alexey V Danilov, Stephen Spurgeon

Leuk Lymphoma· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal Lymphoma: A Review.
Nathan D Gay, Andy Chen, Craig Y Okada

Clin Colon Rectal Surg· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.
Andy I Chen, Jessica T Leonard, Craig Y Okada, Nathan D Gay, Kari Chansky

Leuk Lymphoma· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the programmed cell death 1 pathway in Hodgkin lymphoma: the place of nivolumab.
Nathan D Gay, Craig Y Okada, Andy I Chen, Emma C Scott

Ther Adv Hematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.
Stephen D Smith, Andy Chen, Stephen Spurgeon, Craig Okada, Guang Fan

Ther Adv Hematol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma.
Stephen E Spurgeon, Talia Pindyck, Craig Okada, Yiyi Chen, Zunqiu Chen

Leuk Lymphoma· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression and angiotropism in primary CNS lymphoma.
James L Rubenstein, Jane Fridlyand, Arthur Shen, Ken Aldape, David Ginzinger, Craig Okada

Blood· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma.
Erin Gatza, Craig Y Okada

Cancer Immunol Immunother· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galloping ophthalmoplegia and numb chin in Burkitt lymphoma.
Juan J Chan Lau, Craig Y Okada, Jonathan D Trobe

J Neuroophthalmol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection.
Stacie L Lambert, Craig Y Okada, Ronald Levy

J Immunol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor cell lysate-pulsed dendritic cells are more effective than TCR Id protein vaccines for active immunotherapy of T cell lymphoma.
Erin Gatza, Craig Y Okada

J Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.
John M Timmerman, Debra K Czerwinski, Thomas A Davis, Frank J Hsu, Claudia Benike, Craig Y Okada

Blood· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis